On November 4, GE HEALTHCARE TECHNOLOGIES INC rose 5.12% in Regular Trading, trading at $84.03/share, with turnover of $92.5065 million.
The most recent company-specific catalyst in the news flow was the launch of the Allia Celeo ceiling-mounted imaging system for cardiovascular and interventional radiology procedures. The system combines a wide-bore C-arm, AI-powered imaging and an adjustable interface designed to improve workflow efficiency and imaging coverage in complex procedures.
That event arrived shortly after the company reported stronger third-quarter results on October 28, with adjusted EPS of $1.34 versus $1.20 expected and revenue of $5.51 billion versus $5.35 billion expected, while raising full-year adjusted EPS guidance to $4.95-$5.05 from $4.80-$5.00. Earlier reports also linked the better-than-expected quarter to healthy hospital spending and strength in imaging and diagnostics sales, which provides fundamental support for the stock’s latest rise.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments